Trademark Overview
On Thursday, November 20, 2025, a trademark application was filed for MIVSET with the United States Patent and Trademark Office. The USPTO has given the MIVSET trademark a serial number of 99507779. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 20, 2025. This trademark is owned by Kyverna Therapeutics, Inc.. The MIVSET trademark is filed in the Pharmaceutical Products category with the following description:
Therapeutic pharmaceuticals for the treatment of autoimmune diseases; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease; pharmaceutical preparations and substances for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders